Loading data for SMTI — first visit, this takes a few seconds.

Alerta

Sanara MedTech Inc. (SMTI)

NasdaqCM: SMTI · Precio en tiempo real · USD

34.33

-0.05 (-0.15%)

Al cierre: Aug 12, 2026, 8:00 PM

-0.15% (1D)

No hay datos disponibles

Precio de compra	24.51
Capitalización de mercado	315.6M
Ingresos (TTM)	107.48M
Beneficio neto (TTM)	630.72K
Beta	1.16
EPS (TTM)	0.59
Ratio PER (TTM)	58.19
Adelante PE	63.57
P/B (TTM)	44.76
P/S (TTM)	2.94
Earnings Date	Nov 11, 2026

Precio de venta	44.14
Volumen	321,847
Volumen medio (20D)	157,790
Abierto	34.25
Anterior Cerrar	34.38
Rango del día	34.24 - 34.39
Rango de 52 semanas	16.05 - 35.95
analista	n/a
Precio objetivo	n/a
Dividendos	n/a
Fecha ex dividendo	n/a

Acerca de SMTI

Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns. It also develops BIASURGE, a no-ri...

[Leer más]

Industria Medical Instruments & Supplies

Sector Healthcare

IPO Fecha Apr 7, 1994

Empleados 108

Bolsa de Valores NasdaqCM

Símbolo bursátil SMTI

Sitio web https://sanaramedtech.com

Perfil completo de la empresa

Desempeño financiero

En 2025, los ingresos de Sanara MedTech fueron 103.12M, un aumento de 18.97% en comparación con 86.67M del año anterior. Las ganancias fueron -37.56M, un aumento de 288.66%.

Estados financieros

Sorpresa de resultados

Sanara MedTech ha publicado sus resultados trimestrales en Aug 11, 2026:

Ingresos de $27.8M falla las estimaciones por $0, con 18.62% Crecimiento interanual.

EPS de 0.09 supera las estimaciones en 0.16, con 139.13% Crecimiento interanual.

Próxima publicación de resultados

Está previsto que Sanara MedTech Inc. publique sus resultados el Nov 11, 2026, durante el horario de mercado.
Los analistas proyectan ingresos de ... Actualizar

Noticias

1 semana hace · Zacks

Sanara MedTech Inc. (SMTI) Tops Q2 Earnings Estimates

Sanara MedTech (SMTI) delivered earnings and revenue surprises of +150.00% and -4.30%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

1 semana hace · Motley Fool

MiMedx (MDXG) Q2 2026 Earnings Call Transcript

Surgical revenue grew 15% as wound care stabilized ahead of $350M Sanara deal.

1 semana hace · Zacks

biote Corp. (BTMD) Reports Break-Even Earnings for Q2

biote Corp. (BTMD) delivered earnings and revenue surprises of -100.00% and -5.71%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

2 semanas hace · Moby

MiMedx Group, Inc. Q2 2026 Earnings Call Summary

Moby summary of MiMedx Group, Inc.'s Q2 2026 earnings call

2 semanas hace · GuruFocus.com

MiMedx Group Inc (MDXG) (Q2 2026) Earnings Call Highlights: Surgical Growth and Transformative ...

MiMedx reports strong surgical momentum and a transformational acquisition, while navigating a challenging wound care market with early signs of stabilization.

Página 1 de 2

Sanara MedTech Inc. (SMTI)